Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin and PRT in children with ASD
NCT03370510Phase 2Terminated
- Sponsor
- Yale University
- Start
- Dec 2018
- Primary completion
- Jul 2021
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin nasal spray in Autism Spectrum Disorder (ASD), sponsored by Yale University. Started Dec 2018; status: terminated.
02
Drugs
oxytocin nasal spray
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT03370510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03370510.